XK and influenza: To date, only a few anti-influenza drugs have been licensed to treat influenza infections, including neuraminidase (NA) inhibitors (oseltamivir, zanamivir, peramivir), M2 ion channel inhibitors (amantadine, rimantadine) and polymerase inhibitors (favipiravir, baloxavir) [3], although all have limitations.